NCT05223270

Brief Summary

This study is aimed to examine the effect of different wound dressings on the prevention of pressure injury in the face area related to noninvasive mechanical ventilation mask. The study was completed out with 102 patients who were followed up in Chest Diseases and Thoracic Surgery Hospital between October 2019 and August 2020 and met the inclusion criteria of the study. In the study, hydrocellular and hydrocolloid wound dressing was applied to the pressure areas under the mask of noninvasive mechanical ventilation in the intervention groups, while the routine treatment process was followed in the control group. Wound dressings were obtained from HARTMANN. Study data were collected with the "Individual Characteristics Form" and "Pressure Injury Rating Scale".

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

August 16, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

1 month

First QC Date

August 16, 2021

Last Update Submit

August 9, 2024

Conditions

Keywords

noninvasive mechanical ventilationpressure injurywound dressing

Outcome Measures

Primary Outcomes (7)

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    1st day

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    2nd day

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    3rd day

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    4th day

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    5th day

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    6th day

  • pressure injury stage

    The development of pressure injury in the facial region of the patients after the intervention was evaluated twice a day with the pressure injury scale.

    7th day

Study Arms (3)

intervention group-1

EXPERIMENTAL

Hydrocolloid wound dressings were placed on the pressure areas under the NIMV mask of the patients in this group.

Other: wound dressing under the NIMV mask

intervention group-2

EXPERIMENTAL

Hydrocelluler wound dressings were placed on the pressure areas under the NIMV mask of the patients in this group.

Other: wound dressing under the NIMV mask

control group

NO INTERVENTION

Patients in this group were treated without placing an additional dressing under the NIMV mask.

Interventions

wound dressing under the NIMV mask

intervention group-1intervention group-2

Eligibility Criteria

Age22 Years - 86 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over 18 years, receiving NIMV therapy for at least 6 hours a day, on the first day of hospitalization and followed up for at least 7 days, receiving NIMV treatment with an oro-nasal mask, tolerant of mask,

You may not qualify if:

  • patients with pre-treatment pressure injuries in the facial area, patients with diabetes mellitus, patients with mental or psychological problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Pınar Dogan, Asst.Prof.

    Medipol University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: semi-experimental study with post test, control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst.Prof.

Study Record Dates

First Submitted

August 16, 2021

First Posted

February 3, 2022

Study Start

October 1, 2019

Primary Completion

November 1, 2019

Study Completion

August 1, 2020

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

It will be presented as a Clinical Study Report.

Shared Documents
CSR
Time Frame
It will be used in the period from the completion of the study to the publication of the article (average 15 months).
Access Criteria
Supporting meta-analysis studies that need the data of the study can be shared.

Locations